$124.660
-2.007 (-1.61%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
INBX Prediction & Forecast by Similar Chart Analysis
Alphio's INBX stock price prediction model matches the current Inhibrx Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $126.06 (+1.12%). The 1-week path is $127.15 (+2.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Inhibrx Biosciences Inc Stock?
Inhibrx Inc is a good buy right now due to its current price of $123.41, which is significantly below the analyst price targets of $245 and $325. The stock has shown strong momentum with a 5-day change of +19.09% and a 20-day change of +50.41%, indicating positive market sentiment. However, the main risk lies in its negative earnings, with a reported EPS of -2.34 and a forward P/E of 0, reflecting ongoing challenges in profitability.
INBX stock price ended at $124.66 on Tuesday, after losing -1.61%
Inhibrx Biosciences Inc (INBX) last closed at $124.66, losing -1.61%. These facts feed the 1-day and 1-week INBX price prediction above.
Forecast Drivers
Inhibrx Biosciences Inc (INBX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches INBX, ranked by similarity.
Seasonality analysis for INBX
Historically the probability of a positive September return for INBX is 60.47%. August offers the highest probability of a positive month at 65.62%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for INBX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $7.85 | $9.87 | $11.30 | -92.09% |
| Oct 2026 | $6.02 | $8.86 | $9.80 | -92.89% |
| Nov 2026 | $4.86 | $7.80 | $8.51 | -93.74% |
| Dec 2026 | $5.62 | $6.65 | $8.55 | -94.66% |
In 2026, Inhibrx Biosciences Inc (INBX) is projected to range from $4.86 to $11.30.
Inhibrx Biosciences Inc 2026 monthly forecast
In Sep 2026, Inhibrx Biosciences Inc is projected to average $9.87, with a low of $7.85 and high of $11.30.
In Oct 2026, Inhibrx Biosciences Inc is projected to average $8.86, with a low of $6.02 and high of $9.80.
In Nov 2026, Inhibrx Biosciences Inc is projected to average $7.80, with a low of $4.86 and high of $8.51.
In Dec 2026, Inhibrx Biosciences Inc is projected to average $6.65, with a low of $5.62 and high of $8.55.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.